1. Advancing HIV Drug Resistance Technologies and Strategies: Insights from South Africa's Experience and Future Directions for Resource-Limited Settings.
- Author
-
Steegen, Kim, van Zyl, Gert U., Claassen, Mathilda, Khan, Aabida, Pillay, Melendhran, Govender, Subitha, Bester, Phillip A., van Straaten, Johanna M., Kana, Vibha, Cutler, Ewaldé, Kalimashe, Monalisa N., Lebelo, Ramokone L., Moloi, Mokopi B. H., and Hans, Lucia
- Subjects
RESOURCE-limited settings ,DRUG resistance ,ANTI-HIV agents ,DRUG monitoring ,HIGH-income countries - Abstract
Monitoring of HIV drug resistance (HIVDR) remains critical for ensuring countries attain and sustain the global goals for ending HIV as a public health threat by 2030. On an individual patient level, drug resistance results assist in ensuring unnecessary treatment switches are avoided and subsequent regimens are tailored on a case-by-case basis, should resistance be detected. Although there is a disparity in access to HIVDR testing in high-income countries compared to low- and middle-income countries (LMICS), more LMICs have now included HIVDR testing for individual patient management in some groups of patients. In this review, we describe different strategies for surveillance as well as where HIVDR testing can be implemented for individual patient management. In addition, we briefly review available technologies for HIVDR testing in LMICs, including Sanger sequencing, next-generation sequencing, and some point-of-care options. Finally, we describe how South Africa has implemented HIVDR testing in the public sector. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF